Kenneth Hillan Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Kenneth Hillan.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Kenneth Hillan. Kenneth Hillan is a Director in SANGAMO THERAPEUTICS, INC ($SGMO) and an Chief Executive Officer in Achaogen Inc ($AKAO) and a See Remarks in Achaogen Inc ($AKAO) and a Director in Zymeworks Inc. ($ZYME) and a Director in Relypsa Inc ($RLYP).

Address: C/O ACHAOGEN, INC. 7000 SHORELINE COURT, #371 SOUTH SAN FRANCISCO 94080 CA

Companies in which Kenneth Hillan is an Insider

Achaogen, Inc.

Trading Symbol: AKAO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kenneth Hillan: See Remarks, Chief Executive Officer
Holdings: 248,128 shares
Current Value: $4,677,213
Latest Transaction: Jun 29 2018
$AKAO Market Capitalization: $541.33M
$AKAO Previous Close: $18.85

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Relypsa Inc

Trading Symbol: RLYP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kenneth Hillan: Director
Holdings: 2,250 shares
Latest Transaction: Sep 02 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SANGAMO THERAPEUTICS, INC

Trading Symbol: SGMO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Kenneth Hillan: Director
Holdings: 23,200 shares
Current Value: $89,320
Latest Transaction: Mar 01 2021
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Zymeworks Inc.

Trading Symbol: ZYME
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kenneth Hillan: Director
Holdings: 0 shares
Latest Transaction: May 07 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Kenneth Hillan

Sentiment: All, AKAO, RLYP, SGMO, ZYME

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 07 2021ZYMEZymeworks Inc.Hillan Kenneth J.DirectorOption ExerciseA29.499,000265,4109,000
Mar 01 2021SGMOSANGAMO THERAPEUTI ...Hillan Kenneth J.DirectorOption ExerciseA11.1916,400183,51616,400
Mar 01 2021SGMOSANGAMO THERAPEUTI ...Hillan Kenneth J.DirectorGrantA0.008,200023,20015 K to 23.2 K (+54.67 %)
Sep 11 2020SGMOSANGAMO THERAPEUTI ...Hillan Kenneth J.DirectorOption ExerciseA10.4330,000312,90030,000
Sep 11 2020SGMOSANGAMO THERAPEUTI ...Hillan Kenneth J.DirectorGrantA0.0015,000015,0000 to 15 K
May 12 2020ZYMEZymeworks Inc.Hillan Kenneth J.DirectorOption ExerciseA35.499,000319,4109,000
May 08 2019ZYMEZymeworks Inc.Hillan Kenneth J.DirectorOption ExerciseA19.1110,000191,10010,000

View all Kenneth Hillan insider transactions.